Source: International Congress 2016 – Acute pulmonary embolism
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Aurora Solier Lopez (Sevilla, Spain), Aurora Solier Lopez, Luis Jara Palomares, Teresa Elias Hernandez, Maria Isabel Asensio Cruz, Isabel Blasco Esquivias, Veronica Sanchez Lopez, Elena Arellano Lopez, Lucia Marin Barrera, Lionel Suarez Valdivia, Maria Rodriguez de la Borbolla, Remedios Otero Candelera. Search predictive factors of recurrence in venous thromboembolic disease associated with cancer after withdrawal of the anticoagulation. HISPALIS study. Eur Respir J 2016; 48: Suppl. 60, 2462

Member's Comments

No comment yet.

Related content which might interest you: Clinical characteristics of elderly patients with pulmonary embolism and risk factors for recurrence Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Factors associated with mortality and survival in venous thromboembolism and hidden or concurrent cancer Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015 Recurrence patterns for venous thromboembolism - who is most at risk? Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Risk factors for recurrences in patients with idiopathic pulmonary embolism after withdrawal of long-term anticoagulation Source: Eur Respir J 2006; 28: Suppl. 50, 44s Year: 2006 Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism: results from the REVERSE study Source: Eur Respir J, 59 (2) 2101801; 10.1183/13993003.01801-2021 Year: 2022 Long-term low molecular weight heparin treatment in cancer associated venous thromboembolism patients Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015 Hemorrhagic complications of treatment in patients with pulmonary embolism Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Risk factors for chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2009; 33: 325-331 Year: 2009 Occult cancer in patients with acute venous thromboembolism: Why, when and where to investigate Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016 Clinical and prognostic scores in patients with cancer and pulmonary embolism Source: International Congress 2016 – Acute pulmonary embolism Year: 2016 Late Breaking Abstract - Incidence, risk factors and thrombotic load of pulmonary embolism in patients hospitalized with COVID-19 Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021 Treatment of venous thromboembolism in cancer patients with tinzaparin beyond 6 months. TiCAT study Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016 The diagnosis of malignancy following a venous thromboembolic event - how high is the risk? Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2009; 33: 332-338 Year: 2009 Tinzaparin and vitamin K antagonist (VKA) use in patients with cancer associated venous thromboembolism (VTE): A cohort study Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment Source: Eur Respir J 2016; 48: 1369-1376 Year: 2016 Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial Source: Eur Respir J, 51 (1) 1701202; 10.1183/13993003.01202-2017 Year: 2018 Clinical profile and mortality of patients with pulmonary embolism and cancer Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots Year: 2015 Risk factors in patients with venous thromboembolism Source: Eur Respir J 2002; 20: Suppl. 38, 239s Year: 2002 Risks of pulmonary thromboembolism associated with ambulatory management of clinically proven deep vein thrombosis Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005